The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia

Neuroscience Research

Volumn 68, Issue 2, 2010, Pages 154-157

  Kitamura, Eiji ^a   Hamada, Junichi ^a   Kanazawa, Naomi ^a   Yonekura, Junko ^a   Masuda, Ray ^a   Sakai, Fumihiko ^b   Mochizuki, Hideki ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b International Headache Center   (Japan)

Author keywords

2,3,5 Triphenyltetrazolium chloride (TTC); Brain ischemia; Middle cerebral artery occlusion (MCAO); Neuroprotective effect; Orexin A; Rats

Indexed keywords

OREXIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; HYPOTHALAMUS; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; BRAIN; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HEART RATE; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TIME FACTORS;

EID: 77956296831     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.06.010     Document Type: Article

References (20)

1. Antunes V.R., Brailoiu G.C., Kwok E.H., Scruggs P., Dun N.J. Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am. J. Physiol.Reg. I 2001, 281:R1801-R1807.
2. Astrup J., Siesjö B.K., Symon L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 1981, 12:723-725.
3. Bülbül M., Tan R., Gemici B., Ongüt G., Izgüt-Uysal V.N. Effect of orexin-A on ischemia-reperfusion-induced gastric damage in rats. J. Gastroenterol. 2008, 43:202-207.
4. Dohi K., Nishino S., Nakamachi T., Ohtaki H., Morikawa K., Takeda T., Shioda S., Aruga T. CSF orexin A concentrations and expressions of the orexin-1 receptor in rat hippocampus after cardiac arrest. Neuropeptides 2006, 40:245-250.
5. Feeney D.M., Baron J.C. Diaschisis. Stroke 1986, 17:817-830.
6. Hirota K., Kushikata T., Kudo M., Kudo T., Smart D., Matsuki A. Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats. Brain Res. 2003, 981:143-150.
7. Holland P., Goadsby P.J. The hypothalamic orexinergic system: pain and primary headaches. Headache 2007, 47:951-962.
8. Irving E.A., Harrison D.C., Babbs A.J., Mayes A.C., Campbell C.A., Hunter A.J., Upton N., Parsons A.A. Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neurosci. Lett. 2002, 324:53-56.
9. Jochem J., Zwisrska-korczala K., Zabielski R., Kato I., Kuwahara A. Cardiovascular effects of centrally acting orexin A in haemorrhage-shocked rats. J. Physiol. Pharmacol. 2006, 57:115-124.
10. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kanagawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
11. Memezawa H., Smith M.L., Siesjö B.K. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 1992, 23:552-559.
12. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 1999, 827:243-260.
13. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., Miqnot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 2000, 6:991-997.
14. Sakashita Y., Matsuda H., Kakuda K., Takamori M. Hypoperfusion and vasoreactivity in the thalamus and cerebellum after stroke. Stroke 1993, 24:84-87.
15. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
16. Willie J.T., Chemelli R.M., Sinton C.M., Yanagisawa M. To eat or to sleep? Orexin in the regulation on feeding and wakefulness. Annu. Rev. Neurosci. 2001, 24:429-458.
17. Yamanaka A., Muraki Y., Tsujino N., Goto K., Sakurai T. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem. Biophys. Res. Commun. 2003, 303:120-129.
18. Yonekura J., Hamada J., Kanazawa N., Sakai F. Plasma orexin-A levels in patients with migraine. Kitasato Med. J. 2008, 38:77-80.
19. Yonekura J., Hamada J., Koizumi K., Fukuda M., Maruyama S., Sakai F. The effect of orexin-A on cortical spreading depression. J. Cereb. Blood Flow Metab. 2007, (Suppl. 1):669.
20. Zhang W., Fukuda Y., Kuwaki T. Respiratory and cardiovascular actions of orexin-A in mice. Neurosci. Lett. 2005, 385:131-136.